Table of Contents Table of Contents
Previous Page  136 / 916 Next Page
Show Menu
Previous Page 136 / 916 Next Page
Page Background


25th European Congress of Psychiatry / European Psychiatry 41S (2017) S106–S169


Parents, enrolled in the Odense Child Cohort (OCC),

answered the CBCL/1½–5 when the child reached 27 months of

age. Parents with children above the age of four and a raw score


(90th percentile) on the PDP scale, received the Social Responsive-

ness Scale (SRS) questionnaire. Children with a high score on the

SRS were invited to a clinical examination consisting of ADOS and

ADI-R. Children in OCC were re-assessed with CBCL/1½–5 again at

age five years.


Results will be presented at the EPA conference 2017 in



The results may contribute to enhance the outcome

of treatment by detecting children with ASD at an earlier age.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

e-Poster walk: Co-morbidity/dual pathologies and

guidelines/Guidance – part 1


Prevalence and predictors of ADHD

symptoms in adults admitted for

substance use disorder treatment:

A prospective cohort study

K. Abel

, E. Ravndal , T. Clausen , J. Bramness

Norwegian Center for Addiction Research SERAF, University of Oslo,

Faculty of Medicine, Oslo, Norway

Corresponding author.


Substance use disorders (SUD) are common in

adults with ADHD. A co-occurring ADHD diagnosis is associated

with poorer treatment outcomes for both the ADHD and the SUD

and higher rates of relapse to substance use.


To explore the relationship between ADHD and SUD

longitudinally to identify factors to help improve treatment out-



Prevalence of ADHD symptoms was investigated in a

national cohort of SUD patients one year after SUD treatment initia-

tion. Factors at baseline related to ADHD symptoms were explored

at follow up.


Five hundred and forty-eight individuals were inter-

viewed in a multi-center study involving 21 treatment facilities at

treatment initiation and one year later (


= 261). ADHD symptoms

were measured by the Adult ADHD Self Report Scale (ASRS-v.1-

1) at follow-up. Individuals who screened positively for ADHD

(ADHD + ) were compared to those who screened negatively on

baseline variables. Emotional distress was measured by Hopkin’s

Symptom Check List-25.


At follow-up 35% screened positively for ADHD. In bivari-

ate analysis the ADHD+ group was older, was less likely to have

children, reported lower educational level, had more frequent

use of stimulants, cannabis and benzodiazepines, and experienced

higher degree of emotional stress. When controlling for other sig-

nificant variables in a logistic regression analysis, the ADHD+ group

was associated with more frequent use of cannabis (OR 2.14; CI

1.08–4.23) and of higher psychiatric symptom burden (OR 1.79; CI



A high prevalence of ADHD symptoms and associ-

ated challenges underline the importance of systematic screening

of individuals entering SUD treatment.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.


The duration of undiagnosed bipolar

disorder: Impact of substance use

disorders co-morbidity

S. Ben Mustapha

, W. Homri , L. Jouini , R. Labbane

Razi Hospital, service de psychiatrie C, Mannouba, Tunisia

Corresponding author.


Study the impact of substance use disorders (SUD) co-

morbidity on the duration of undiagnosed bipolar disorder (DUBP).


Case-control study during a period of six months from

July 2015 to December 2015. One hundred euthymic patients with

BD (type I, II or unspecified) were recruited in the department of

psychiatry C Razi Hospital, during their follow-up. Two groupswere

individualized by the presence or not of a SUD co-morbidity. In our

study DUBP was defined as the period between the first symptoms

and the beginning of treatment by a mood stabilizer.


The beginning of addictive behaviour preceded the instal-

lation of bipolar disease in 32% of cases. Installation of bipolar

disorder preceded the installation of addictive behaviour in 12% of

cases. The beginning of addictive behaviour was concomitant with

the installation of bipolar disease in 6% of cases. The average DUBP

in the full sample was 4.80 years with a standard deviation of 8.04

and extremes ranging from 0.08 to 37.5.

The average DUBP in patients with SUD co-morbidity was 5.91

years with a standard deviation of 8.16 and extremes ranging from

0.08 to 35, and 3.68 years with a standard deviation of 7.84 and

extremes ranging from 0.08 to 37.5 in patients without SUD co-



According to studies over two thirds of patients with

bipolar disorder received misdiagnoses before diagnosis of BD,

and among the factors involved can report the presence of SUD

co-morbidity. Hence, we should detect BD among patients with


Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.


Smoking, preparing the patient with

a severe mental disorder for change

G.M. Chauca Chauca

1 ,

, M.J. Jaén Moreno


, M.I. Osuna Carmona



J.A. Alcalá Partera


, A.B. Rico del Viejo


, F. Sarramea Crespo



Instituto Maimónides de Investigación Biomédica de Córdoba.

Hospital Infanta Margarita, Universidad de Córdoba, Cabra, Córdoba,



Instituto Maimónides de Investigación Biomédica de Córdoba

IMIBIC, Hospital Universitario Reina Sofía. Universidad de Córdoba,

Córdoba, Spain


Instituto Maimónides de Investigación Biomédica de Córdoba

IMIBIC, Hospital Universitario Virgen de la Victoria.

USMC-Fuengirola. Universidad de Córdoba, Córdoba, Spain

Corresponding author.


Smoking is a serious health problem for people with

mental illness like the bipolar disorder patients. The developmental

of motivational tools such as brief intervention it is necessary in the

context of community care.


Evaluating the change inmotivational stage after brief

intervention and evaluating the clinical and smoking factors in rela-

tion with this.


Two hundred and twenty patients diagnosedwith bipo-

lar disorder (according DSM-5 criteria) that were in the euthymic

phase (defined as less than 7 points in YMRS and 10 points in HDRS)

and attended the community care centers of three provinces of

Andalusia (Spain). Patients who consumed in the last month qual-

ified for the level of motivation for change (measured by URICA